Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) gapped up prior to trading on Tuesday following a stronger than expected earnings report. The stock had previously closed at $29.25, but opened at $31.65. Harmony Biosciences shares last traded at $33.42, with a volume of 677,286 shares traded. The company reported $0.67 earnings per share […]
Harmony Biosciences (NASDAQ:HRMY – Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.60 by $0.07, Yahoo Finance reports. Harmony Biosciences had a net margin of 22.16% and a return on equity of 27.49%. The business had revenue of $154.62 million […]
Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Needham & Company LLC in a research report issued on Tuesday, Benzinga reports. They currently have a $50.00 price target on the stock. Needham & Company LLC’s price target suggests a potential upside of 70.94% from the stock’s […]
Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a research report issued on Tuesday, Benzinga reports. They presently have a $50.00 target price on the stock. Needham & Company LLC’s target price suggests a potential upside of 70.94% from the company’s […]
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating and six have assigned a buy rating to the company. The average 12 month target […]